Javascript must be enabled to continue!
Tet2-mediated macrophage activation promotes liver regeneration
View through CrossRef
Abstract
Objective Macrophages are predominant immune cells that secret IL-6 and HGF to promote liver regeneration after liver resection. Ten-eleven translocation- 2 (Tet2) DNA dioxygenase regulates the secretion of pro-inflammatory factors in macrophages. In this study, we explored the role of Tet2 in macrophages and its function independent of its enzymatic activity in liver regeneration.
Methods A 70% partial hepatectomy mice model was established. Enzyme-linked immunosorbent assays, quantitative reverse transcription-polymerase chain reaction, western blotting, immunofluorescences, and flow cytometry were performed to explore the infiltration and phenotypes of immune cells in mice models. Molecular dynamics simulations were carried out to study the interaction of Tet2 with Stat1.
Results We found Tet2 in macrophages negatively regulates liver regeneration in the partial hepatectomy mice model. In mechanism, Tet2 interacts with Stat1 to inhibit the expressions of proinflammatory factors and suppress liver regeneration. Tet2 inhibitor BC339 attenuated the interaction of Stat1 and Tet2, enhanced Stat1 phosphorylation, and promoted hepatocyte proliferation. Notably, Tet2 also directly affected hepatocyte proliferation, independent of the IL-6-Stat3 signaling pathway.
Conclusion Tet2 in macrophages negatively regulates liver regeneration via interacting with Stat1. Our results suggest that specific targeting Tet2 in macrophages promotes the recovery of liver function after hepatectomy. Keywords Macrophage, Liver regeneration, partial hepatectomy, Tet2.
Research Square Platform LLC
Title: Tet2-mediated macrophage activation promotes liver regeneration
Description:
Abstract
Objective Macrophages are predominant immune cells that secret IL-6 and HGF to promote liver regeneration after liver resection.
Ten-eleven translocation- 2 (Tet2) DNA dioxygenase regulates the secretion of pro-inflammatory factors in macrophages.
In this study, we explored the role of Tet2 in macrophages and its function independent of its enzymatic activity in liver regeneration.
Methods A 70% partial hepatectomy mice model was established.
Enzyme-linked immunosorbent assays, quantitative reverse transcription-polymerase chain reaction, western blotting, immunofluorescences, and flow cytometry were performed to explore the infiltration and phenotypes of immune cells in mice models.
Molecular dynamics simulations were carried out to study the interaction of Tet2 with Stat1.
Results We found Tet2 in macrophages negatively regulates liver regeneration in the partial hepatectomy mice model.
In mechanism, Tet2 interacts with Stat1 to inhibit the expressions of proinflammatory factors and suppress liver regeneration.
Tet2 inhibitor BC339 attenuated the interaction of Stat1 and Tet2, enhanced Stat1 phosphorylation, and promoted hepatocyte proliferation.
Notably, Tet2 also directly affected hepatocyte proliferation, independent of the IL-6-Stat3 signaling pathway.
Conclusion Tet2 in macrophages negatively regulates liver regeneration via interacting with Stat1.
Our results suggest that specific targeting Tet2 in macrophages promotes the recovery of liver function after hepatectomy.
Keywords Macrophage, Liver regeneration, partial hepatectomy, Tet2.
Related Results
High Incidence of TET2 Mutation in Chinese Patients with MDS and AML with Previous History of MDS
High Incidence of TET2 Mutation in Chinese Patients with MDS and AML with Previous History of MDS
Abstract
Abstract 4943
Myelodysplastic syndromes(MDS) are a heterogeneous group of myeloid neoplasms characterized by cytopenia, dysplasia in one or m...
EVALUATION AND COMPARISON OF LIVER MARKERS IN ACUTE LIVER FAILURE VS CHRONIC LIVER FAILURE IN DISTRICT FAISALABAD: A CROSS-SECTIONAL STUDY
EVALUATION AND COMPARISON OF LIVER MARKERS IN ACUTE LIVER FAILURE VS CHRONIC LIVER FAILURE IN DISTRICT FAISALABAD: A CROSS-SECTIONAL STUDY
Background: Liver failure is a life-threatening clinical condition resulting from the inability of the liver to maintain its metabolic, synthetic, and detoxification functions. Acu...
D-mannose alleviates chronic periodontitis in rats by regulating the functions of neutrophils
D-mannose alleviates chronic periodontitis in rats by regulating the functions of neutrophils
Abstract
Background
Periodontitis is a chronic inflammatory disease without effective treatment. Nowadays, the critical role of neutrophils in periodontitis is getting bet...
Phylogenetic Analysis of TET2 Gene Variants in Pakistani Acute Myeloid Leukemia Patients
Phylogenetic Analysis of TET2 Gene Variants in Pakistani Acute Myeloid Leukemia Patients
Abstract
Background
Acute myeloid leukemia (AML) is a heterogeneous malignancy caused by the proliferation of neoplastic myeloid progenit...
Anti-inflammatory and Antifibrotic Effects of Harpullia cupanioides L. Leaves in Thioacetamide-Induced Liver Fibrosis in Rats
Anti-inflammatory and Antifibrotic Effects of Harpullia cupanioides L. Leaves in Thioacetamide-Induced Liver Fibrosis in Rats
Introduction:
Inflammation is mainly caused by cellular and vascular factors. Lymphocytes and macrophages
are among the circulating cellular constituents. It is...
Impaired Function of Fancc-/- Immune Cells.
Impaired Function of Fancc-/- Immune Cells.
Abstract
Abstract 1494
Fanconi anemia (FA) is a genetic disorder characterized by bone marrow (BM) failure, developmental defects and cancer predispos...
Abstract 1427: Sensitizing HL60 acute myeloid leukemia cells to decitabine with pterostilbene
Abstract 1427: Sensitizing HL60 acute myeloid leukemia cells to decitabine with pterostilbene
Abstract
Introduction. Decitabine (DAC), is a DNA hypomethylating agent that has been shown to be potent towards leukemia cells at low doses. However, many patients ...
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Abstract
Background: Imetelstat, a first in class specific telomerase inhibitor, induced hematologic responses in all patients (pts) with essential thrombocythemia (...

